Literature DB >> 2504470

Effects of culture conditions on yield of Shiga-like toxin-IIv from Escherichia coli.

D L MacLeod1, C L Gyles.   

Abstract

The effects of selected culture conditions on production of Shiga-like toxin-II variant by an edema disease strain of Escherichia coli (412) and E. coli TB1 (pCG6) containing the cloned genes for Shiga-like toxin-II variant were examined. Incubation time, culture media, incubation temperature, starting pH of the culture medium, aeration, static culture, anaerobiosis, carbon sources, amino acids, antibiotics, and mitomycin C were investigated. The study showed that Shiga-like toxin-II variant was primarily cell associated and that strain TB1 (pCG6) produced as much as 100 times more toxin than did strain 412. Culture conditions that resulted in the greatest yield of Shiga-like toxin-II variant were incubation at 37 degrees C for 24 h with shaking in syncase broth initially adjusted to pH 8.5. Aerobic culture with shaking resulted in higher yields of Shiga-like toxin-II variant than did static aerobic or anaerobic culture. Addition of various carbon sources or amino acids, or tetracycline, lincomycin, or trimethoprim:sulfadoxine did not increase yields of toxin. The amount of Shiga-like toxin-II variant in supernatant preparations from strain TB1 (pCG6) was significantly increased by addition of mitomycin C to the culture medium.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2504470     DOI: 10.1139/m89-100

Source DB:  PubMed          Journal:  Can J Microbiol        ISSN: 0008-4166            Impact factor:   2.419


  11 in total

1.  Detection and production of verotoxin 1 of Escherichia coli O157:H7 in food.

Authors:  R D Weeratna; M P Doyle
Journal:  Appl Environ Microbiol       Date:  1991-10       Impact factor: 4.792

2.  Purification and characterization of an Escherichia coli Shiga-like toxin II variant.

Authors:  D L MacLeod; C L Gyles
Journal:  Infect Immun       Date:  1990-05       Impact factor: 3.441

3.  Physicochemical and biological properties of purified Escherichia coli Shiga-like toxin II variant.

Authors:  D L MacLeod; C L Gyles; A Valdivieso-Garcia; R C Clarke
Journal:  Infect Immun       Date:  1991-04       Impact factor: 3.441

4.  Direct evidence of neuron impairment by oral infection with verotoxin-producing Escherichia coli O157:H- in mitomycin-treated mice.

Authors:  J Fujii; T Kita; S Yoshida; T Takeda; H Kobayashi; N Tanaka; K Ohsato; Y Mizuguchi
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

5.  Impact of free verotoxin testing on epidemiology of diarrhea caused by verotoxin-producing Escherichia coli.

Authors:  K Ramotar; E Henderson; R Szumski; T J Louie
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

6.  Direct detection of verotoxin-producing Escherichia coli in stool samples by PCR.

Authors:  K Ramotar; B Waldhart; D Church; R Szumski; T J Louie
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

7.  Regulation of the Shiga-like toxin II operon in Escherichia coli.

Authors:  I Mühldorfer; J Hacker; G T Keusch; D W Acheson; H Tschäpe; A V Kane; A Ritter; T Olschläger; A Donohue-Rolfe
Journal:  Infect Immun       Date:  1996-02       Impact factor: 3.441

8.  Adaptation of Escherichia coli O157:H7 to pH alters membrane lipid composition, verotoxin secretion, and resistance to simulated gastric fluid acid.

Authors:  Hyun-Gyun Yuk; Douglas L Marshall
Journal:  Appl Environ Microbiol       Date:  2004-06       Impact factor: 4.792

9.  The N-terminal domain of EspF induces host cell apoptosis after infection with enterohaemorrhagic Escherichia coli O157:H7.

Authors:  Suhui Zhao; Ying Zhou; Chunhui Wang; Yu Yang; Xianbo Wu; Yao Wei; Li Zhu; Wei Zhao; Qiwei Zhang; Chengsong Wan
Journal:  PLoS One       Date:  2013-01-25       Impact factor: 3.240

Review 10.  Shiga toxins and the pathophysiology of hemolytic uremic syndrome in humans and animals.

Authors:  Chad L Mayer; Caitlin S Leibowitz; Shinichiro Kurosawa; Deborah J Stearns-Kurosawa
Journal:  Toxins (Basel)       Date:  2012-11-08       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.